The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers.

MLA

Guo Wang, et al. “The CYP2C19 Ultra-Rapid Metabolizer Genotype Influences the Pharmacokinetics of Voriconazole in Healthy Male Volunteers.” European Journal of Clinical Pharmacology, vol. 65, no. 3, Mar. 2009, pp. 281–85. EBSCOhost, https://doi.org/10.1007/s00228-008-0574-7.

APA

Guo Wang, He-Ping Lei, Zhi Li, Zhi-Rong Tan, Dong Guo, Lan Fan, Yao Chen, Dong-Li Hu, Dan Wang, & Hong-Hao Zhou. (2009). The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers. European Journal of Clinical Pharmacology, 65(3), 281–285. https://doi.org/10.1007/s00228-008-0574-7

Chicago

Guo Wang, He-Ping Lei, Zhi Li, Zhi-Rong Tan, Dong Guo, Lan Fan, Yao Chen, Dong-Li Hu, Dan Wang, and Hong-Hao Zhou. 2009. “The CYP2C19 Ultra-Rapid Metabolizer Genotype Influences the Pharmacokinetics of Voriconazole in Healthy Male Volunteers.” European Journal of Clinical Pharmacology 65 (3): 281–85. doi:10.1007/s00228-008-0574-7.